Eastgate Biotech Corp.
						ETBI
					
					
							
								$0.00
								$0.000.00%
								
							
						OTC PK
					
				| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -93.77% | 745.16% | -- | -- | -- | 
| Total Receivables | -96.69% | -- | -- | -- | -- | 
| Inventory | -- | -- | -- | -- | -- | 
| Prepaid Expenses | -- | -- | -- | -- | -- | 
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- | 
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- | 
| Other Current Assets | -- | -- | -- | -- | -- | 
| Total Current Assets | -82.22% | 10,080.65% | -- | -- | 381.93% | 
| 
										 | 
								|||||
| Total Current Assets | -82.22% | 10,080.65% | -- | -- | 381.93% | 
| Net Property, Plant & Equipment | -16.96% | -- | -- | -- | -- | 
| Long-term Investments | -- | -- | -- | -- | -- | 
| Goodwill | -- | -- | -- | -- | -- | 
| Total Other Intangibles | -- | -- | -- | -- | -- | 
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- | 
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- | 
| Total Other Assets | -- | -- | -- | -- | -- | 
| Total Assets | -6.80% | 19,168.82% | -- | -- | 580.28% | 
| 
										 | 
								|||||
| Total Accounts Payable | 41.39% | 9.13% | 51.48% | 4.02% | -5.75% | 
| Total Accrued Expenses | 8.95% | 10.98% | 2.46% | 13.82% | 20.52% | 
| Short-term Debt | 14.48% | 32.96% | 6.55% | 10.51% | 2.68% | 
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- | 
| Finance Division Debt Current | 1,489.03% | 127.88% | 0.00% | 2.97% | 18.82% | 
| Total Finance Division Other Current Liabilities | 1.27% | 0.85% | 0.97% | -2.62% | 0.00% | 
| Total Other Current Liabilities | 1.27% | 0.85% | 0.97% | -2.62% | 0.00% | 
| Total Current Liabilities | 19.68% | 18.85% | 6.90% | 11.55% | 10.89% | 
| 
										 | 
								|||||
| Total Current Liabilities | 19.68% | 18.85% | 6.90% | 11.55% | 10.89% | 
| Long-Term Debt | -- | -- | -- | -- | -- | 
| Short-term Debt | 14.48% | 32.96% | 6.55% | 10.51% | 2.68% | 
| Capital Leases | -- | -- | 0.00% | -3.38% | -13.93% | 
| Finance Division Debt Non Current | -- | -- | -- | -- | -- | 
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- | 
| Total Other Liabilities | -- | -- | -- | -- | -- | 
| Total Liabilities | 19.68% | 17.88% | 6.84% | 11.40% | 10.57% | 
| 
										 | 
								|||||
| Common Stock & APIC | 8.31% | 14.91% | 6.58% | 0.80% | 0.00% | 
| Retained Earnings | -12.89% | -4.59% | -6.51% | -4.05% | -3.48% | 
| Treasury Stock & Other | -307.53% | 104.20% | -27.96% | 78.03% | 25.99% | 
| Total Common Equity | -31.46% | 18.28% | -6.64% | -11.40% | -12.75% | 
| 
										 | 
								|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- | 
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- | 
| Preferred Stock Convertible | -- | -- | -- | -- | -- | 
| Preferred Stock, Others | -- | -- | -- | -- | -- | 
| Total Preferred Equity | -- | -- | -- | -- | -- | 
| 
										 | 
								|||||
| Total Common Equity | -31.46% | 18.28% | -6.64% | -11.40% | -12.75% | 
| Total Preferred Equity | -- | -- | -- | -- | -- | 
| Total Minority Interest | -- | -- | -- | -- | -- | 
| Total Equity | -31.47% | 18.28% | -6.64% | -11.40% | -12.75% | 
| 
										 | 
								|||||